The Mycobacteria Research Laboratories, founded in 1986, is an internationally recognized research and training center within the Department of Microbiology, Immunology, and Pathology. With access to exceptional facilities and resources, the center leads fundamental and translational research to understand mycobacterial diseases and pathogens, and innovate models of disease, diagnostics, therapeutics, and vaccines. Members collaborate extensively with center peers, university colleagues, and a host of scientific partners around the world. Through teaching, training, and outreach, members have a global influence on the understanding and treatment of mycobacterial diseases.
Thank you for investing in scientific research and discovery. Donate Now
news and updates view all
For World TB Day, CSU scientists take their tuberculosis research on the road
Leaders in mycobacteria research are renewing efforts to bring the next generation of researchers to the table to make new discoveries and win the long game against tuberculosis and related diseases.
Tuberculosis researchers find link between vaccine efficacy, environmental pathogens
Researchers at CSU are among the foremost experts on Mycobacterium tuberculosis, the causative agent of the disease, and have for many years been dedicated to understanding its underlying immunopathology.
CSU researchers take a major role in identifying leprosy in wild chimpanzees
An international team that includes researchers John Spencer, Ph.D., and Charlotte Avanzi, Ph.D., of the Colorado State University Mycobacteria Research Laboratories has identified leprosy in wild chimpanzees in the West African countries of Guinea-Bissau and Ivory Coast.
1682 Campus Delivery
Colorado State University
Fort Collins, CO 80523-1682